RNV
- Rounds on record
- 0
What matters now
- 3 investorsnamed
3 investors on record.
The investors already on the cap table shape who leads the next round.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 0
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
Who would invest
How comparable investors are foundComparable investors backed two or more of the companies this company’s own investors also back. Broader fit co-invested two or more times with them and dated a new company in the last 12 months. Each reason is a fact on record: a shared company, a co-investment count, a dated deal, a stage or round size it has joined. A shared sector alone never puts a firm here. Nothing is a prediction that a firm will invest.Already invested
3 investors on record- Francisco Partners portfolio listing Fact mobihealthnews.com
- General Catalyst portfolio listing Fact mobihealthnews.com
- Solas Bioventures Management, LLC portfolio listing Fact solasbio.com
Strong comparable investors
0 firmsFirms that backed two or more of the companies this company's own investors also back.
No firm backed two or more of the companies this company's investors back, so there is no comparable investor on record yet.
Broader fit
2 firmsFirms that co-invest repeatedly with this company's investors and dated a new company in the last 12 months.
- Andreessen Horowitz
- Co-invested 5 times with 1 of this company's investors
- 23 new companies dated in the last 12 months, latest Oct 1, 2026
- Led 53% of 30 rounds whose lead is known
- Followed on in 15% of its companies
- 24 funds raising or deploying (newest vintage 2026)
- Y Combinator
- Co-invested 5 times with 1 of this company's investors
- 31 new companies dated in the last 12 months, latest Sep 29, 2026
- Led 8% of 36 rounds whose lead is known
- Followed on in 3% of its companies
- 8 funds raising or deploying (newest vintage 2026)
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 1 listingeach firm's own card, as read
- Status not stated on Solas Bioventures Management, LLC · the firm's card prints no outcome · read Sep 16, 2026 solasbio.com“RNV”
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
Timeline
Evidence
Every observation on this company
- Investors named on site: 2 Oct 1, 2026 Fact Company website
- Listed on portfolio page: Solas Bioventures Management, LLC Sep 16, 2026 Fact Firm website
- Listed on portfolio page: Solas Bioventures Management, LLC Sep 14, 2026 Fact Firm website
- Website status: ok Oct 1, 2026 Fact Company website
- Site title: Oct 1, 2026 Fact Company website
Relationships across DFX
56 capital paths
RNV sits on 56 traced paths of capital across the graphs.
DFX traced 56 paths of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…